Peptide therapy costs vary enormously depending on which category you're in, brand-name FDA-approved drug, insurance-covered prescription, compounded version, or unregulated research chemical, and that variation itself tells you something important.
Brand-Name GLP-1 Medications
Without insurance, brand-name GLP-1 drugs like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) have historically listed around $1,000 to $1,400 per month in the U.S., though manufacturer savings programs, cash-pay direct programs, and negotiated prices have shifted this considerably and continue to change. Insurance coverage, when available, can reduce out-of-pocket costs dramatically, though coverage for weight-management use specifically has historically been inconsistent compared to coverage for type 2 diabetes.
Compounded Versions
When these drugs were in official shortage, compounded versions were often available at a fraction of brand-name cost, sometimes a few hundred dollars a month. That pricing gap reflects avoiding brand markup and marketing costs, but as the FDA has narrowed the legal basis for compounding these specific drugs outside shortage conditions, availability and legality of compounded GLP-1s has become more restricted and continues to evolve.
Research Chemical and Recovery Peptides
Peptides like BPC-157, TB-500, and various growth hormone secretagogues sold as research chemicals tend to be priced much lower per vial, often tens of dollars, reflecting the absence of clinical trial costs, GMP manufacturing, and regulatory oversight built into that price. Low price in this category isn't a sign of good value, it's largely a reflection of what oversight has been skipped.
What Actually Drives Cost
Across all categories, price is driven by manufacturing standards, clinical trial investment, regulatory compliance, distribution markup, and, for telehealth models, the cost of medical consultation and monitoring built into the service. A useful mental exercise when comparing prices across sources is asking specifically what that price difference is paying for, or not paying for, rather than assuming cheaper is simply a better deal.
A Practical Note
Costs and coverage policies in this space have shifted quickly in recent years and are likely to keep shifting. Any specific number should be treated as a snapshot rather than a permanent fact, and checking current pricing directly with a pharmacy, insurer, or manufacturer program remains the most reliable way to get an accurate figure.
Hidden Costs to Factor In
The advertised price per vial or per month rarely tells the whole story. Required consultation fees, follow-up lab work, supplies like needles and alcohol swabs, and the cost of managing side effects, whether that's over-the-counter anti-nausea medication for a GLP-1 or a doctor visit if something goes wrong, all add to the real cost of a peptide regimen. When comparing options, it's worth pricing out the full course of treatment, not just the sticker price of the vial, especially for anything marketed as a like-for-like bargain replacement for a more expensive, more thoroughly regulated product.